Improving mucociliary clearance in chronic obstructive pulmonary disease
Patients with COPD usually experience mucus hypersecretion as a result of airway inflammation and response to noxious stimuli. These in turn lead to worsening airway resistance, impaired airflow, increased work of breathing, dyspnoea and exercise intolerance. Mucus hypersecretion may also lead to increased exacerbations and poor health related quality of life (HRQL). Institution based pulmonary rehabilitation programs incorporating airway clearance techniques have been shown to improve HRQL, reduce dyspnoea and improve exercise tolerance but are often difficult to provide due to restricted accessibility and resource implications. This review examines the current evidence base and best clinical practice in the area of airway clearance. Mechanical devices such as the flutter valves, positive end expiratory pressure and high frequency chest wall oscillation (HFCWO) may be able to provide the benefits of improved airway clearance in the patient's home potentially with reduced demands on healthcare resources.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2009 |
---|---|
Erschienen: |
2009 |
Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
---|---|
Enthalten in: |
Respiratory medicine - 103(2009), 4 vom: 15. Apr., Seite 496-502 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bhowmik, Angshu [VerfasserIn] |
---|
Links: |
---|
Themen: |
3OWL53L36A |
---|
Anmerkungen: |
Date Completed 22.02.2010 Date Revised 21.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.rmed.2008.10.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM185259677 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM185259677 | ||
003 | DE-627 | ||
005 | 20231223172134.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2009 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.rmed.2008.10.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n0618.xml |
035 | |a (DE-627)NLM185259677 | ||
035 | |a (NLM)19091536 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bhowmik, Angshu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Improving mucociliary clearance in chronic obstructive pulmonary disease |
264 | 1 | |c 2009 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.02.2010 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Patients with COPD usually experience mucus hypersecretion as a result of airway inflammation and response to noxious stimuli. These in turn lead to worsening airway resistance, impaired airflow, increased work of breathing, dyspnoea and exercise intolerance. Mucus hypersecretion may also lead to increased exacerbations and poor health related quality of life (HRQL). Institution based pulmonary rehabilitation programs incorporating airway clearance techniques have been shown to improve HRQL, reduce dyspnoea and improve exercise tolerance but are often difficult to provide due to restricted accessibility and resource implications. This review examines the current evidence base and best clinical practice in the area of airway clearance. Mechanical devices such as the flutter valves, positive end expiratory pressure and high frequency chest wall oscillation (HFCWO) may be able to provide the benefits of improved airway clearance in the patient's home potentially with reduced demands on healthcare resources | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Diuretics, Osmotic |2 NLM | |
650 | 7 | |a Expectorants |2 NLM | |
650 | 7 | |a Saline Solution, Hypertonic |2 NLM | |
650 | 7 | |a Mannitol |2 NLM | |
650 | 7 | |a 3OWL53L36A |2 NLM | |
700 | 1 | |a Chahal, Kamaljeet |e verfasserin |4 aut | |
700 | 1 | |a Austin, Gillian |e verfasserin |4 aut | |
700 | 1 | |a Chakravorty, Indranil |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiratory medicine |d 1993 |g 103(2009), 4 vom: 15. Apr., Seite 496-502 |w (DE-627)NLM012605247 |x 1532-3064 |7 nnns |
773 | 1 | 8 | |g volume:103 |g year:2009 |g number:4 |g day:15 |g month:04 |g pages:496-502 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmed.2008.10.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 103 |j 2009 |e 4 |b 15 |c 04 |h 496-502 |